S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
66,000% upside on tiny biotech? (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
The perfect AI stock under $10 (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
66,000% upside on tiny biotech? (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
The perfect AI stock under $10 (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
66,000% upside on tiny biotech? (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
The perfect AI stock under $10 (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
66,000% upside on tiny biotech? (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
The perfect AI stock under $10 (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
Free Stock Analysis Report: See The True Value of Any Stock (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
NASDAQ:ATEC

Alphatec (ATEC) Stock Price, News & Analysis

$15.27
-0.12 (-0.78%)
(As of 02/23/2024 ET)
Today's Range
$14.88
$15.69
50-Day Range
$13.55
$16.78
52-Week Range
$8.66
$19.14
Volume
1.54 million shs
Average Volume
1.26 million shs
Market Capitalization
$2.08 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.63

Alphatec MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
48.2% Upside
$22.63 Price Target
Short Interest
Bearish
8.31% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-1.67
Upright™ Environmental Score
News Sentiment
-0.25mentions of Alphatec in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$572,271 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.44) to ($1.00) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.04 out of 5 stars

Medical Sector

185th out of 942 stocks

Surgical & Medical Instruments Industry

21st out of 90 stocks


ATEC stock logo

About Alphatec Stock (NASDAQ:ATEC)

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. It manufactures and sells implants and instruments through third-party suppliers. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform; Sigma PTP Access and Patient Positioning System; split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; EOS imaging system that provides full-body imaging; spinal implants and fixation systems; and NanoTec and Calibrate PSX, as well as various standalone implants for height restoration and stabilization. It also provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix, a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM; AlphaGRAFT Demineralized Bone Matrix comprising demineralized human tissues; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives in the United States and internationally. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

ATEC Stock Price History

ATEC Stock News Headlines

Hidden stock is secret key to AI like ChatGPT (Trades for less than $5)
One of the world's great stock experts is doing something crazy. He outed the details of an obscure AI stock that trades under a hidden name.
Alphatec (ATEC) Scheduled to Post Earnings on Tuesday
Insurance Co Federal's Net Worth
A Weird Income Tactic So Simple and So Lucrative...
It Has Billionaires JOKING About It! There's an unusual income tactic Warren Buffett has relied on time and time again for BILLIONS in dividend payouts. Carl Icahn once joked it was "like taking candy from a baby."  
Strong Buy: Alphatec’s Sustained Growth and Robust Financial Outlook
Alphatec: Still Not Having My Back
Q3 2023 Alphatec Holdings Inc Earnings Call
Alphatec GAAP EPS of -$0.35
ATEC Nov 2023 10.000 call
See More Headlines
Receive ATEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alphatec and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/04/2021
Today
2/24/2024
Next Earnings (Confirmed)
2/27/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:ATEC
CUSIP
02081G10
Employees
705
Year Founded
1990

Price Target and Rating

Average Stock Price Target
$22.63
High Stock Price Target
$32.00
Low Stock Price Target
$17.00
Potential Upside/Downside
+48.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
7 Analysts

Profitability

Net Income
$-152,150,000.00
Pretax Margin
-38.43%

Debt

Sales & Book Value

Annual Sales
$350.87 million
Book Value
($0.35) per share

Miscellaneous

Free Float
96,610,000
Market Cap
$2.08 billion
Optionable
Optionable
Beta
1.67

Social Links

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report














ATEC Stock Analysis - Frequently Asked Questions

Should I buy or sell Alphatec stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alphatec in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ATEC shares.
View ATEC analyst ratings
or view top-rated stocks.

What is Alphatec's stock price target for 2024?

7 Wall Street analysts have issued 12-month price objectives for Alphatec's shares. Their ATEC share price targets range from $17.00 to $32.00. On average, they predict the company's stock price to reach $22.63 in the next year. This suggests a possible upside of 48.2% from the stock's current price.
View analysts price targets for ATEC
or view top-rated stocks among Wall Street analysts.

How have ATEC shares performed in 2024?

Alphatec's stock was trading at $15.11 on January 1st, 2024. Since then, ATEC shares have increased by 1.1% and is now trading at $15.27.
View the best growth stocks for 2024 here
.

When is Alphatec's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024.
View our ATEC earnings forecast
.

How can I listen to Alphatec's earnings call?

Alphatec will be holding an earnings conference call on Tuesday, February 27th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 800-770-2030 with passcode "97241".

How were Alphatec's earnings last quarter?

Alphatec Holdings, Inc. (NASDAQ:ATEC) released its quarterly earnings data on Thursday, November, 4th. The medical technology company reported ($0.43) earnings per share for the quarter, missing the consensus estimate of ($0.23) by $0.20. The medical technology company had revenue of $62.88 million for the quarter, compared to the consensus estimate of $61.43 million. During the same period in the prior year, the firm earned ($0.18) earnings per share.

What ETFs hold Alphatec's stock?
What guidance has Alphatec issued on next quarter's earnings?

Alphatec issued an update on its FY 2023 earnings guidance on Monday, January, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $481.1 million-$482.7 million, compared to the consensus revenue estimate of $472.5 million.

What is Pat Miles' approval rating as Alphatec's CEO?

19 employees have rated Alphatec Chief Executive Officer Pat Miles on Glassdoor.com. Pat Miles has an approval rating of 72% among the company's employees. 63.0% of employees surveyed would recommend working at Alphatec to a friend.

What other stocks do shareholders of Alphatec own?
Who are Alphatec's major shareholders?

Alphatec's stock is owned by a variety of retail and institutional investors. Top institutional investors include First Light Asset Management LLC (4.39%), Vanguard Group Inc. (3.96%), Point72 Asset Management L.P. (2.20%), Cerity Partners LLC (1.38%), Royal Bank of Canada (1.18%) and Oberweis Asset Management Inc. (1.18%). Insiders that own company stock include Craig E Hunsaker, David H Mowry, David M Demski, David R Pelizzon, David Sponsel, Elizabeth Ann Altman, Evan Bakst, James L L Tullis, James L L Tullis, Jason Hochberg, Jeffrey G Black, Jennifer N Pritzker, Jennifer N Pritzker, John Todd Koning, L-5 Healthcare Partners, Llc, Mortimer Berkowitz III, Patrick Miles, Paul Segal and Scott Lish.
View institutional ownership trends
.

How do I buy shares of Alphatec?

Shares of ATEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ATEC) was last updated on 2/25/2024 by MarketBeat.com Staff